- Cancer Genetics update29 days ago
An Emerging Leader in Cancer Diagnostics
Cancer Genetics, Inc. (CGI) is an emerging leader in the field of personalized medicine, offering diagnostic products and services that enable precision medicine in the field of oncology.
Products and services being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state-of-the-art reference laboratory provide critical genomic information where patients and their physicians need it most – to diagnose, monitor and inform cancer treatment.
CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our clinical reference laboratory is both CLIA-certified and CAP-accredited. In addition we have approvals and accreditations from the states of Florida, Maryland, New York, California, and New Jersey. Our clinical trial support services and global facilities help biotech and biopharma companies deliver more personalized treatments to market.
CGI is focused on delivering products and services that drive the highest levels of patient value. To achieve this, we have developed a corporate culture that inspires innovation, respects knowledge and fosters leadership. Our dedicated staff takes pride in our specialized laboratory services, superior turnaround time (TAT), enhanced reporting, EMR integration, and ongoing research and development for new tests. CGI’s full-service cancer genetic practice and path to innovation with research makes for optimal patient care management.
With locations in the US, India, and China, we are helping to empower personalized cancer treatment around the globe.
Cancer Genetics, Inc. was founded by world-renowned cytogeneticist Dr. R.S.K. Chaganti. Today, CGI’s scientific advisory board includes key thought leaders in the areas of hematological malignancies, solid tumor cancers, pharmacogenomics, and clinical trials administration. Built on a foundation of world-class scientific knowledge and IP in solid and blood-borne cancers, the company continues to develop strong research collaborations with major cancer centers and academic institutions.
In 2013, CGI launched a joint-venture with Mayo Clinic, Oncospire Genomics. Working to meet areas of critical need in oncology, Oncospire Genomics seeks to improve cancer care by discovering and commercializing diagnostic tests that leverage NGS technology.
In 2014, CGI acquired Gentris, LLC (based in Raleigh, NC) and Bioserve Biotechnologis Pvt. Ltd. (based in Hyderabad, India. Gentris | A CGI Company is a market leader in providing pharmacogenomics testing, genotyping, and biorepository services to the pharmaceutical and biotech industries. Gentris advances personalized medicine by partnering with pharmaceutical, academic, and technology leaders to effectively integrate pharmacogenomics into their drug development and clinical trial programs with the goals of delivering safer, more effective drugs to market more quickly, and improving patient care. Gentris’ clinical trials services, as well as their international services and Shanghi, China operations, have been integrated into CGI’s Select One® clinical trials offering, allowing CGI to provide the most robust and personalized clinical trial services available to our biotech and pharma customers.
Based in Hyderabad, India, BioServe India (now Cancer Genetics India) was the first company to provide DNA synthesis, DNA sequencing, and related services in India. Cancer Genetics India brings Indian cientists, pharmaceutical companies, and research institutes a ‘Biomaterial to Data’ model that offers a full suite of molecular services and research tools to accelerate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics. CG-India’s customers include nearly every Indian Council of Medical Research (ICMR) and Council for Scientific and Industrial Research (CSIR) institute and several major pharmaceutical and biotechnology companies, as well as top industry and academic researchers.
CGI is an expanding personalized medicine company, focused on cancer treatment through molecular diagnostics, genomics research, and comprehensive and integrated laboratory testing services. We are dedicated to the mission of providing genomic solutions to the clinical, biopharmaceutical, and research communities.
Our state-of-the art laboratory, centrally located in Rutherford, NJ, and just minutes from NYC.
CGI offers comprehensive benefits, competitive compensation and an innovative environment that encourages active learning and scientific inquiry. The company has been ranked amongst the 20 best places to work in the industry by the The Scientist Magazine.
Cancer Genetics Photos
RecommendsPositive OutlookApproves of CEO
- Work/Life Balance
- Culture & Values
- Career Opportunities
- Comp & Benefits
- Senior Management
I have been working at Cancer Genetics full-time (Less than a year)
Coming from Top 5 labs of the world with more than decade of experience, I have never come across such a wonderful company and especially CEO (Panna Sharma) who has this impeccable vision in the life sciences industry. It is a true leader like him and the right team he is forming that is making the biggest difference for patients and pharma who are developing innovative cancer therapies. For anyone to have an ultimate job satisfaction you would need a leader who is also a mentor with a smart vision but also for a humane cause. The CEO is a true gem in the lab industry, with a passionate goal to help patients. He is so kind to spend time and hear to the voice of his employees which he ultimately applies to help the patients. A true leader like him is very much necessary in this competitive space for a stable, long term productive strategy.The CEO's vision and strategy with the right team is the key to the success !! He is a true GEM in the life sciences lab arena in my more than 10 years of lab experience ! It is not how many years of experience but the timing and kind of experience is very much mandatory with the lab space and Panna Sharma is on a true mission for CGI to bring value and hope to patients lives.
The only cons is the lab market is moving at an unbelievable direction with mergers and joint ventures just like in the pharma world. Recently, 4 major labs became 2 depriving pharma of lab partners for their clinical trial testing needs, But CGI with the CEO vision is a true hope to be a strong, consistent player by driving positive growth. There is a strong need especially for pharma programs to have partnership with labs like CGI for their world wide clinical trials. Ultimately, the goal of CGI is help approve new and life chagrining drugs to be accessible to patients. That is the best job satisfaction anyone should look into as we as a company are helping other lives in need. If employees see this need in the lab community they will understand the high energy goals that CGI has to develop the credibility across physicians and pharma.
Advice to Management
KEEP UP THE POSITIVE VISION AND LET US MAKE A DIFFERENCE IN PATIENT'S LIVES !!
Getting an Interview
Getting an Interview
- No OfferPositive ExperienceEasy Interview
I applied in-person. The process took 3 weeks. I interviewed at Cancer Genetics (Rutherford, NJ) in January 2015.
Very methodical done by the CEO. There was a very clear understanding of mutual goals which gives the credibility for the new hire and the management to understand the vision.
- Behavioral assessment to make sure positive culture is coming. Many series of questions about the goals to help the life sciences lab industry Answer Question
Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services with some of the most prestigious medical institutions in the world. Products and services being developed at CGI are poised to transform patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state-of-the-art reference ...
Mission: Our Mission: Empowering personalized cancer treatment that will increase treatment efficacy, and reduce healthcare costs. Our Values: Our core values are built around the respect of the patient and the desire to provide quality service. Knowledge | Innovation | Leadership | Collaboration